1.
To Assess the Beneficial Effects of Rosuvastatin Before Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome. mfm [Internet]. 2024 Oct. 1 [cited 2025 Dec. 26];30(10). Available from: https://medicalforummonthly.com/index.php/mfm/article/view/4945